75A50126C00005 - ISOLA THERAPEUTICS INC | Federal Contract Management | Prosal

75A50126C00005

ActiveMulti-Year

ISOLA THERAPEUTICS INC

Department of Health and Human Services › Office of Assistant Secretary for Preparedness and Response › BARDA - ASPR / DAAPPO / BARDA DCMA

EZ-BAA-22-100-SOL-00003

$7.5M

Awarded Apr 27, 2026

Competition

FULL AND OPEN COMPETITION

Offers

Set-Aside

None

Solicitation Type

BASIC RESEARCH

Performance Timeline

Start

May 1, 2026

Performance Start

Current End

Potential End

Completed Period

Recompete Intelligence

18months until recompete window

Estimated start: Oct 31, 2027

Winner Profile

ISOLA THERAPEUTICS INC

Contract: 75A50126C00005

UEI

M3QDM72NME75

Parent Company

ISOLA THERAPEUTICS INC

Capabilities & Certifications

Category BusinessCorporate Entity Not Tax ExemptSmall BusinessSpecial DesignationsU.S.-Owned Business

Headquarters Location

4408 WASHBURN AVE S, MINNEAPOLIS, MN, 55410

Congressional District: 05

Contract Value Analysis

Current Obligation

$7,485,417

Base + Exercised Options

$7,485,417

Total Ceiling Value

$7,485,417

Contract Value Consumed$7.5M of $7.5M (100%)

Over 75% of contract value has been obligated. Options or modifications may be needed soon.

Contract Type

FIRM FIXED PRICE

Multi-Year Contract

Contract Modifications & History

Work Scope & Classification

Description

THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES.

NAICS

541715

RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

54├Professional, Scientific, and Technical Services

5417├Scientific Research and Development Services

541715└Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC

AN13

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

A├RESEARCH AND DEVELOPMENT

AN├N – Health R&D Services

AN13└HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

Place of Performance

MINNEAPOLIS, MN, 55410

Congressional District: 05

Customer Agency Details

Awarding Agency

Department of Health and Human Services

Top-tier Agency

Office of Assistant Secretary for Preparedness and Response

Sub-tier Agency

BARDA - ASPR / DAAPPO / BARDA DCMA

Office

Funding Agency

Department of Health and Human Services

Top-tier Agency

Office of Assistant Secretary for Preparedness and Response

Sub-tier Agency

BARDA - ASPR / DAAPPO / BARDA DCMA

Office

75A50126C00005

ISOLA THERAPEUTICS INC

Additional Contract Details